$207.98−4.52 (−2.13%)
At close: Nov 16, 2026, 4:00 PM ET· Nasdaq · USD
iShares Biotechnology ETF (IBB) Price
Sources Fund holdings disclosures and market prices Fund disclosures and pricesPrice as of How we compute thisNot investment advice
Price
Loading chart…
Price return, distributions not included.
Snapshot
Equity · HealthcareIssuer: ISharesNAV $213.57 (Nov 12)Expense ratio
0.44%
annual fee
Assets
$11.1B
as of Nov 12, 2026
Holdings
243
positions
Distribution yield (TTM)
0.2%
as of Nov 13, 2026
Inception
2001
launch year
THE VERDICT
A sector position. At a 0.44% fee and 0.2% distribution yield, the fee eats into returns over time. Its largest tilt is Healthcare (~100%).
This label comes from the fund's own properties: what it holds, its category, asset class, expense ratio, yield, leverage and whether it pays regular income. Nothing about the reader enters it, and it is not the Tenet Score.
At a glance
the case for and againstWhy own it
▲Launched 2001.
Watch out for
▼Concentrated tilt: Healthcare make up ~100% of the basket.
Best suited for
Investors who want targeted exposure to one industry or theme and accept that it can move very differently from the broad market.
Basket · as of Nov 12, 2026

